The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences The Amino zing World of Peptide Regulation ArentFox Schiff Is BPC 157 Legal? Understanding Its Status and Implications FDA Peptide Reclassification 2026: What It Means for Providers